Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-01-02 @ 8:26 AM
Study NCT ID:
NCT01925950
Status:
TERMINATED
Last Update Posted:
2018-11-01
First Post:
2013-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)
Sponsor:
Soligenix
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Gastrointestinal Graft vs Host Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | BDP | View |
| None | orBec | View |
| None | GVHD | View |
| None | beclomethasone dipropionate | View |
| None | bone marrow transplant | View |
| None | hematopoietic cell transplant | View |
| None | HCT | View |
| None | stem cell transplant | View |
| None | marrow transplant | View |
| None | SCT | View |
| None | beclomethasone 17,21-dipropionate | View |